Targeted Cancer Drugs Show Promise for Children with Rare RAS-Mutated Cancers
Targeted cancer drugs already used in adults may also help treat childhood cancers carrying rare G12C mutations, according to new research from the NCI’s Center for Cancer Research scientists.
